MaxWell Webinar with Prof. Dr. János Vörös and Dr. Vaiva Vasiliauskaitė

Register
Register
Date & Time

Thursday, June 26, 2025 | 17:00 CEST

08:00 PDT | 11:00 EDT | 23:00 CST | 00:00 JST

Tags
MaxOne
Neuronal Cell Cultures
Microphysiological Systems
HD-MEAs
Neurocomputing
Functional Phenotyping
Disease Modeling

Webinar Hightlights

Register
Register

The webinar covered

  • Micro- and nano-channel PDMS platforms enable directional neuronal network fabrication at single-neuron resolution.
  • Integration with patient primary or iPSC-derived cells enables precise, personalized disease modeling.
  • A biophysical modeling approach coupled with neuronal networks on a chip enables quantification of synaptic receptor alterations in isolated neuronal pairs.
  • Application of information theory reveals increased feedback motifs and enhanced information transfer in glioblastoma-infiltrated neuronal networks
Register
Register

Agenda

Thursday, June 26, 2025 | 17:00 CEST

Single-cell level control of neural networks on HD-MEAs for fundamental neuroscience and disease modeling

Prof. Dr. János Vörös

Abstract

Diseases of the human nervous system are one of the leading cause of death, scary and often painful. Unfortunately, it is very difficult to find new drugs for these diseases, because preclinical drug testing on animals have little predictive value on human safety/toxicity and especially on efficacy. Recent progress in human induced pluripotent stem cell (iPSC) technology in combination with emerging microphysiological systems (MPS) might provide an opportunity to address some of the challenges related to investigating the nervous system and its diseases. This talk will introduce new tools to create and to interact with well-defined neuronal networks in vitro. PDMS microchannels enable directional connections with single-neuron level control while nanochannels enable the tuning of the connectivity between pre- and postsynaptic neurons. This allows the creation of arbitrary network architectures with real neurons to study fundamental neuroscience paradigms while maintaining a tight connection to experiments. At the same time, it is also compatible with human iPSC-derived cells and primary cells from patients enabling precise disease models towards personalized medicine.

Thursday, June 26, 2025 | 17:00 CEST

Integrated in vitro platform and in silico modelling approaches for studying synaptic transmission and glioblastoma effects in neuronal circuits

Dr. Vaiva Vasiliauskaitė

Abstract

Advances in Microelectrode Arrays (MEAs) and in human induced pluripotent stem cell technology have enabled the collection of data with high spatiotemporal resolution. Integrating MEAs with microstructured platforms presents a powerful approach that offers high-throughput and long-term recordings of neuronal networks with precise connectivity, which can be used to study fundamental neural processes such as learning and modelling of human diseases. To optimally navigate the multidimensional parameter space of each experiment, we are developing new computational modelling methods which can optimize experimental protocols and offer in silico hypotheses testing.

In this talk, I will highlight two applications of computational modelling integrated with in vitro platforms. First, I will present a biophysical modelling approach based on Hodgkin-Huxley formalism and likelihood-free inference. Coupled with an experimental platform, capable of isolating and recording from single neuronal pairs, this approach enables quantification of AMPA and NMDA receptor-specific alterations following long-term potentiation stimulation. Second, we examined a clinically-relevant application of how glioblastoma – the most aggressive and prevalent primary brain tumor in adults – disrupts neuronal information transmission at the local circuit level. Using information theory to extract functional connectivity and network science to characterize the resulting functional network structure, we found that glioblastoma-infiltrated networks exhibit a higher prevalence of local feedback motifs and increased information transfer during population bursts. Together, these findings highlight the need for experimentally relevant biophysical models of plastic, reconfigurable neuronal networks to elucidate the mechanisms driving network reorganization in both disease and learning-related plasticity.

Speakers

Prof. Dr. János Vörös

Laboratory of Biosensors and Bioelectronics, Institute for Biomedical Engineering, ETH Zurich (Switzerland)

Biography

János Vörös has studied Physics at the Eötvös Loránd University in Budapest. After receiving a diploma in Physics in 1995, he was a doctoral student at the Department of Biological Physics of the Eötvös University (in collaboration with Microvacuum Ltd.) where he received his PhD in Biophysics in 2000. Since 1998 he was a member of the Biolnterface group in the Laboratory for Surface Science and Technology at the Department of Materials of ETH Zurich as visiting scientist, postdoc, and from 2004 as group leader of the Dynamic Biointerfaces group until 2006. Prof. Vörös is interested in research and teaching in the areas of Biosensors, Bioelectronics and Bottom-up Neuroscience. His research group focuses on the development of novel biosensor techniques for diagnostics and drug discovery and on interacting with well-defined neural networks for experimentally guided computational neuroscience.

Abstract

Dr. Vaiva Vasiliauskaitė

Institute for Biomedical Engineering at ETH Zürich, ETH Zurich (Switzerland)

Biography

Vaiva Vasiliauskaite has studied Physics at the University of Glasgow. After receiving a diploma in Theoretical Physics in 2016, she was a doctoral student at the Centre for Complexity Science and Theoretical Physics group, where she worked on mathematical modelling of directed networks and received a PhD in Physics 2020. From 2020 to 2024 she was a postdoctoral researcher in the Computational Social Science group at ETH Zurich where her work combined network science, dynamical systems, and deep learning, with applications to social and financial systems. In 2024, she joined the Laboratory of Biosensors and Bioelectronics, where she is developing experimentally relevant computational models of in vitro neuronal networks for disease modelling and basic neuroscience applications.

Abstract

Hosts

Marie Obien

CCO | MaxWell Biosystems (Switzerland)

Biography

Recording available

Sign Up for the Updates
Sign Up for the Updates
Access the recording
Access the recording

Register

You can unsubscribe from marketing emails at any time. For details, see our Privacy Policy.

Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
MaxWell